Back to mobile site

More on BIOS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.8 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- M&A (N/A)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BIOS Cash Flow Statement

Click line-items for a historical chart and %
Net (loss) income -29.04M
Depreciation 12.96M
Amortization of intangibles
Amortization of deferred financing costs
Change in deferred income tax
Compensation under stock-based compensation plans 3.35M
Loss on disposal of fixed assets
Receivables, net of bad debt expense 6.72M
Inventory 12.8M
Prepaid expenses and other assets 9.16M
Accounts payable -31.25M
Claims payable
Amounts due to plan sponsors
Accrued interest
Accrued expenses and other liabilities
Net cash provided by (used in) operating activities -38.54M
Purchases of property and equipment, net
Cash consideration paid to CHS, net of cash acquired
Net cash used in investing activities -71.38M
Proceeds from new credit facility, net of fees paid to issuers 84M
Borrowings on line of credit
Repayments on line of credit
Repayments of capital leases -525K
Principal payments on CHS long-term debt, paid at closing
Principal payments on long-term debt
Deferred and other financing costs 0
Net proceeds from exercise of employee stock compensation plans
Surrender of stock to satisfy minimum tax withholding
Net cash (used in) provided by financing activities 97.18M
Net change in cash and cash equivalents -12.74M
Cash and cash equivalents - end of period 15.58M
Cash and cash equivalents - end of period 2.84M
Cash paid during the period for interest 30.13M
Cash paid during the period for income taxes, net of refunds 260K